Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 619

1.

[A marked decrease of orexin in the cerebrospinal fluid in a patient with myotonic dystrophy type 1 showing an excessive daytime sleepiness].

Iwata T, Suzuki N, Mizuno H, Nakashima I, Kanbayashi T, Itoyama Y.

Rinsho Shinkeigaku. 2009 Jul;49(7):437-9. Japanese.

PMID:
19715174
[PubMed - indexed for MEDLINE]
2.

Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.

Martínez-Rodríguez JE, Lin L, Iranzo A, Genis D, Martí MJ, Santamaria J, Mignot E.

Sleep. 2003 May 1;26(3):287-90.

PMID:
12749547
[PubMed - indexed for MEDLINE]
3.

Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.

Compta Y, Santamaria J, Ratti L, Tolosa E, Iranzo A, Muñoz E, Valldeoriola F, Casamitjana R, Ríos J, Marti MJ.

Brain. 2009 Dec;132(Pt 12):3308-17. doi: 10.1093/brain/awp263. Epub .

PMID:
19858078
[PubMed - indexed for MEDLINE]
Free Article
4.

Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?

Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti CL.

J Neurol. 2005 Feb;252(2):139-45.

PMID:
15729517
[PubMed - indexed for MEDLINE]
5.

The hypocretin neurotransmission system in myotonic dystrophy type 1.

Ciafaloni E, Mignot E, Sansone V, Hilbert JE, Lin L, Lin X, Liu LC, Pigeon WR, Perlis ML, Thornton CA.

Neurology. 2008 Jan 15;70(3):226-30. doi: 10.1212/01.wnl.0000296827.20167.98.

PMID:
18195268
[PubMed - indexed for MEDLINE]
6.

Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.

Nishino S, Kanbayashi T.

Sleep Med Rev. 2005 Aug;9(4):269-310. Review.

PMID:
16006155
[PubMed - indexed for MEDLINE]
7.

Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.

Nakamura M, Kanbayashi T, Sugiura T, Inoue Y.

J Sleep Res. 2011 Mar;20(1 Pt 1):45-9. doi: 10.1111/j.1365-2869.2010.00870.x.

PMID:
20642748
[PubMed - indexed for MEDLINE]
Free Article
8.

[Excessive daytime sleepiness and low CSF orexin-A/hypocretin-I levels in a patient with probable progressive supranuclear palsy].

Hattori Y, Hattori T, Mukai E, Mori H, Mizuno Y, Kayukawa Y, Okada T, Kanbayashi T.

No To Shinkei. 2003 Dec;55(12):1053-6. Japanese.

PMID:
14870576
[PubMed - indexed for MEDLINE]
9.

The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).

Bassetti C, Gugger M, Bischof M, Mathis J, Sturzenegger C, Werth E, Radanov B, Ripley B, Nishino S, Mignot E.

Sleep Med. 2003 Jan;4(1):7-12.

PMID:
14592354
[PubMed - indexed for MEDLINE]
10.

Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.

Baumann CR, Khatami R, Werth E, Bassetti CL.

J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):402-4.

PMID:
16484654
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy.

Gibbs JW 3rd, Ciafaloni E, Radtke RA.

Sleep. 2002 Sep 15;25(6):662-5.

PMID:
12224846
[PubMed - indexed for MEDLINE]
12.

Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.

Martinez-Rodriguez JE, Seppi K, Cardozo A, Iranzo A, Stampfer-Kountchev M, Wenning G, Tolosa E, Högl B, Santamaria J, Poewe W; SINBAR (Sleep Innsbruck Barcelona) group.

Mov Disord. 2007 Sep 15;22(12):1822-4.

PMID:
17659646
[PubMed - indexed for MEDLINE]
13.

Hypersomnolence and increased REM sleep with low cerebrospinal fluid hypocretin level in a patient after removal of craniopharyngioma.

Tachibana N, Taniike M, Okinaga T, Ripley B, Mignot E, Nishino S.

Sleep Med. 2005 Nov;6(6):567-9. Epub 2005 Aug 5.

PMID:
16084764
[PubMed - indexed for MEDLINE]
14.

Narcolepsy and the hypocretins.

Wurtman RJ.

Metabolism. 2006 Oct;55(10 Suppl 2):S36-9. Review.

PMID:
16979425
[PubMed - indexed for MEDLINE]
15.

Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.

Knudsen S, Jennum PJ, Korsholm K, Sheikh SP, Gammeltoft S, Frederiksen JL.

Mult Scler. 2008 Jul;14(6):734-8. doi: 10.1177/1352458508088939. Epub 2008 May 27.

PMID:
18505777
[PubMed - indexed for MEDLINE]
16.

Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.

Taiwo OB, Russell IJ, Mignot E, Lin L, Michalek JE, Haynes W, Xiao Y, Zeitzer JM, Larson AA.

Sleep Med. 2007 Apr;8(3):260-5. Epub 2007 Mar 21.

PMID:
17369087
[PubMed - indexed for MEDLINE]
17.

Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.

Baumann CR, Dauvilliers Y, Mignot E, Bassetti CL.

Eur Neurol. 2004;52(2):73-6. Epub 2004 Jul 13.

PMID:
15256827
[PubMed - indexed for MEDLINE]
18.

[Excessive daytime sleepiness, central type sleep apnea and myotonic dystrophy].

Reimão R, Lemmi H, Bertorini T.

Arq Neuropsiquiatr. 1985 Dec;43(4):391-5. Portuguese.

PMID:
3833140
[PubMed - indexed for MEDLINE]
19.

Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.

Tsukamoto H, Ishikawa T, Fujii Y, Fukumizu M, Sugai K, Kanbayashi T.

Neuropediatrics. 2002 Feb;33(1):51-2.

PMID:
11930279
[PubMed - indexed for MEDLINE]
20.

A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1.

Laberge L, Bégin P, Dauvilliers Y, Beaudry M, Laforte M, Jean S, Mathieu J.

J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):642-6. doi: 10.1136/jnnp.2008.165035. Epub 2009 Feb 11.

PMID:
19211594
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk